GX-19

GX-19 DNA vaccine · Genexine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX-19, covering 2025-08-20 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults [Phase 1, Phase 2]